{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:24:06Z","timestamp":1793431446888,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018955","name":"Leeds Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jaut.2021.102662","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T16:43:53Z","timestamp":1621442633000},"page":"102662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":140,"special_numbering":"C","title":["Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection"],"prefix":"10.1016","volume":"121","author":[{"given":"Dennis","family":"McGonagle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Bridgewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2021.102662_bib1","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","author":"Cines","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102662_bib2","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102662_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2021.04.006","article-title":"Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination - a report of two UK cases","author":"Mehta","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.jaut.2021.102662_bib4","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1016\/S2665-9913(20)30420-3","article-title":"COVID-19 vasculitis and novel vasculitis mimics","volume":"3","author":"McGonagle","year":"2021","journal-title":"Lanc Rheumatol"},{"key":"10.1016\/j.jaut.2021.102662_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/joim.13267","article-title":"Chest pain mimicking pulmonary embolism may be a common presentation of COVID-19 in ambulant patients without other typical features of infection","author":"Harrison","year":"2021","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jaut.2021.102662_bib6","author":"Chadwick"},{"issue":"3","key":"10.1016\/j.jaut.2021.102662_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02737634","article-title":"Heparin-induced thrombocytopenia and thrombosis","volume":"16","author":"Arepally","year":"1998","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"19","key":"10.1016\/j.jaut.2021.102662_bib8","first-page":"1883","article-title":"Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"983","key":"10.1016\/j.jaut.2021.102662_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/pgmj.2007.059188","article-title":"Heparin induced thrombocytopenia: diagnosis and management update","volume":"83","author":"Ahmed","year":"2007","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.jaut.2021.102662_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.trsl.2020.04.014","article-title":"Pathogenesis of heparin-induced thrombocytopenia","volume":"225","author":"Arepally","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.jaut.2021.102662_bib11","doi-asserted-by":"crossref","first-page":"173751","DOI":"10.1016\/j.ejphar.2020.173751","article-title":"COVID-19 vaccine: a recent update in pipeline vaccines, their design and development strategies","volume":"892","author":"Rawat","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.jaut.2021.102662_bib12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","article-title":"Immunological considerations for COVID-19 vaccine strategies","volume":"20","author":"Jeyanathan","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.jaut.2021.102662_bib13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41577-020-00455-1","article-title":"Keeping track of the SARS-CoV-2 vaccine pipeline","volume":"20","author":"Parker","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2021.102662_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.coph.2006.03.001","article-title":"Angiotensin-converting enzyme 2 in lung diseases","volume":"6","author":"Kuba","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102662_bib15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","article-title":"SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jaut.2021.102662_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur. J. Intern. Med."},{"issue":"7","key":"10.1016\/j.jaut.2021.102662_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2021.102662_bib18","doi-asserted-by":"crossref","first-page":"151645","DOI":"10.1016\/j.anndiagpath.2020.151645","article-title":"Severe COVID-19: a multifaceted viral vasculopathy syndrome","volume":"50","author":"Magro","year":"2021","journal-title":"Ann. Diagn. Pathol."},{"issue":"11","key":"10.1016\/j.jaut.2021.102662_bib19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jaut.2021.102662_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad","year":"2021","journal-title":"Vaccines"},{"issue":"7","key":"10.1016\/j.jaut.2021.102662_bib21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-2600(20)30243-5","article-title":"Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans","volume":"8","author":"Fox","year":"2020","journal-title":"Lanc Respir Med"},{"issue":"7","key":"10.1016\/j.jaut.2021.102662_bib22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S2213-2600(20)30244-7","article-title":"Increased cardiovascular mortality in African Americans with COVID-19","volume":"8","author":"McGonagle","year":"2020","journal-title":"Lanc Respir Med"},{"issue":"6","key":"10.1016\/j.jaut.2021.102662_bib23","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.jaut.2021.102662_bib24","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/S2665-9913(20)30121-1","article-title":"Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia","volume":"2","author":"McGonagle","year":"2020","journal-title":"Lanc Rheumatol"},{"issue":"3","key":"10.1016\/j.jaut.2021.102662_bib25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00134-020-06326-6","article-title":"Absence of SARS-CoV-2 RNA in COVID-19-associated intestinal endothelialitis","volume":"47","author":"Stahl","year":"2021","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jaut.2021.102662_bib26","article-title":"Resistance of endothelial cells to SARS-CoV-2 infection <em>in vitro<\/em>","author":"Ahmetaj-Shala","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jaut.2021.102662_bib27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2147\/JIR.S271768","article-title":"Coagulation disorders in COVID-19: role of toll-like receptors","volume":"13","author":"Biswas","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.jaut.2021.102662_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ajem.2020.09.065","article-title":"Thrombotic complications of COVID-19","volume":"39","author":"Avila","year":"2021","journal-title":"Am. J. Emerg. Med."},{"issue":"12","key":"10.1016\/j.jaut.2021.102662_bib29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.dld.2020.09.025","article-title":"Splanchnic vein thrombosis in COVID-19: a review of literature","volume":"52","author":"Singh","year":"2020","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jaut.2021.102662_bib30","doi-asserted-by":"crossref","first-page":"118431","DOI":"10.1016\/j.lfs.2020.118431","article-title":"SARS-CoV-2 and coagulation disorders in different organs","volume":"260","author":"Vinayagam","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.jaut.2021.102662_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(21)00213-7","article-title":"A tri-compartmental model of lung oxygenation disruption in severe COVID-19 explains pulmonary and systemic pathology","author":"McGonagle","year":"2021","journal-title":"Lanc Respirat Med"},{"issue":"1","key":"10.1016\/j.jaut.2021.102662_bib32","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1038\/s41467-020-19057-5","article-title":"SARS-CoV-2 viral load is associated with increased disease severity and mortality","volume":"11","author":"Fajnzylber","year":"2020","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.jaut.2021.102662_bib33","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.0608647104","article-title":"Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation","volume":"104","author":"Kannemeier","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jaut.2021.102662_bib34","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41467-019-09607-x","article-title":"The role of platelets in mediating a response to human influenza infection","volume":"10","author":"Koupenova","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.jaut.2021.102662_bib35","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/jth.15283","article-title":"Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia","volume":"19","author":"Nazy","year":"2021","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.jaut.2021.102662_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.htct.2021.01.007","article-title":"COVID-19 and bleeding at unusual locations: report of four cases","author":"Singh","year":"2021","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.jaut.2021.102662_bib37","article-title":"SARS-CoV-2 RNAemia predicts clinical deterioration and extrapulmonary complications from COVID-19","author":"Ram-Mohan","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jaut.2021.102662_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-9560-11-7","article-title":"Emphasis on the role of PF4 in the incidence, pathophysiology and treatment of heparin induced thrombocytopenia","volume":"11","author":"Prechel","year":"2013","journal-title":"Thromb. J."},{"issue":"15","key":"10.1016\/j.jaut.2021.102662_bib39","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA covid-19 vaccine in a nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102662_bib40","doi-asserted-by":"crossref","first-page":"n1046","DOI":"10.1136\/bmj.n1046","article-title":"Covid-19: unusual blood clots are \"very rare side effect\" of Janssen vaccine, says EMA","volume":"373","author":"Mahase","year":"2021","journal-title":"BMJ"},{"issue":"20","key":"10.1016\/j.jaut.2021.102662_bib41","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1182\/blood-2012-06-389445","article-title":"Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders","volume":"120","author":"Cines","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102662_bib42","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.jaut.2021.102662_bib43","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJM198010023031404","article-title":"Heparin-associated thrombocytopenia","volume":"303","author":"Cines","year":"1980","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jaut.2021.102662_bib44","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood-2005-08-3122","article-title":"Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications","volume":"107","author":"Rauova","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jaut.2021.102662_bib45","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2021.01.007","article-title":"Heparin prevents caspase-11-dependent septic lethality independent of anticoagulant properties","volume":"54","author":"Tang","year":"2021","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.jaut.2021.102662_bib46","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood-2010-08-301424","article-title":"Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia","volume":"117","author":"Krauel","year":"2011","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.jaut.2021.102662_bib47","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1182\/blood-2012-06-434985","article-title":"Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4\/heparin-like epitopes","volume":"120","author":"Krauel","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102662_bib48","article-title":"Towards understanding ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia (VITT)","author":"Greinacher","year":"2021","journal-title":"Res. Sq."},{"issue":"9","key":"10.1016\/j.jaut.2021.102662_bib49","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ncprheum0895","article-title":"Nature and functions of autoantibodies","volume":"4","author":"Elkon","year":"2008","journal-title":"Nat. Clin. Pract. Rheumatol."},{"issue":"2","key":"10.1016\/j.jaut.2021.102662_bib50","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/bjh.14603","article-title":"The unique immunological features of heparin-induced thrombocytopenia","volume":"177","author":"Staibano","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.jaut.2021.102662_bib51","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood.V84.11.3691.bloodjournal84113691","article-title":"Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia","volume":"84","author":"Warkentin","year":"1994","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jaut.2021.102662_bib52","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/jth.13003","article-title":"Heparin enhances uptake of platelet factor 4\/heparin complexes by monocytes and macrophages","volume":"13","author":"Joglekar","year":"2015","journal-title":"J. Thromb. Haemostasis"},{"issue":"23","key":"10.1016\/j.jaut.2021.102662_bib53","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2010-03-276964","article-title":"Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia","volume":"116","author":"Rauova","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jaut.2021.102662_bib54","article-title":"Heparin-induced thrombocytopenia: pathophysiology, diagnosis and management","volume":"12","author":"Patriarcheas","year":"2020","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jaut.2021.102662_bib55","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/s41467-019-09683-z","article-title":"CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-alpha production in systemic sclerosis","volume":"10","author":"Lande","year":"2019","journal-title":"Nat. Commun."},{"issue":"1\u20132","key":"10.1016\/j.jaut.2021.102662_bib56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0891-5849(96)00283-3","article-title":"Immunogenicity of DNA damaged by reactive oxygen species--implications for anti-DNA antibodies in lupus","volume":"22","author":"Cooke","year":"1997","journal-title":"Free Radic. Biol. Med."},{"issue":"3\u20134","key":"10.1016\/j.jaut.2021.102662_bib57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/08830180600785868","article-title":"Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides","volume":"25","author":"Wilson","year":"2006","journal-title":"Int. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2021.102662_bib58","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"Bode","year":"2011","journal-title":"Expert Rev. Vaccines"},{"issue":"10","key":"10.1016\/j.jaut.2021.102662_bib59","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jaut.2021.102662_bib60","article-title":"Diverse functional autoantibodies in patients with COVID-19","author":"Wang","year":"2020","journal-title":"medRxiv"},{"issue":"17","key":"10.1016\/j.jaut.2021.102662_bib61","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6515","key":"10.1016\/j.jaut.2021.102662_bib62","first-page":"370","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jaut.2021.102662_bib63","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/cts.12805","article-title":"Clinical and autoimmune characteristics of severe and critical cases of COVID-19","volume":"13","author":"Zhou","year":"2020","journal-title":"Clin Transl Sci"},{"issue":"21","key":"10.1016\/j.jaut.2021.102662_bib64","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.jacc.2016.02.073","article-title":"Heparin-induced thrombocytopenia: a comprehensive clinical review","volume":"67","author":"Salter","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"20","key":"10.1016\/j.jaut.2021.102662_bib65","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1182\/blood-2008-10-186064","article-title":"Studies of the immune response in heparin-induced thrombocytopenia","volume":"113","author":"Warkentin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102662_bib66","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2106075","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination - response from the manufacturer","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.jaut.2021.102662_bib67","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1002\/1873-3468.13696","article-title":"Innate immunity to adenovirus: lessons from mice","volume":"593","author":"Atasheva","year":"2019","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.jaut.2021.102662_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040877","article-title":"Thrombocytopenia in virus infections","volume":"10","author":"Raadsen","year":"2021","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.jaut.2021.102662_bib69","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1182\/blood-2006-06-032524","article-title":"Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance","volume":"109","author":"Othman","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jaut.2021.102662_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004546","article-title":"Virus-induced NETs--critical component of host defense or pathogenic mediator?","volume":"11","author":"Jenne","year":"2015","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.jaut.2021.102662_bib71","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med"},{"issue":"12","key":"10.1016\/j.jaut.2021.102662_bib72","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.120.048488","article-title":"Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy","volume":"142","author":"Nicolai","year":"2020","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jaut.2021.102662_bib73","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.jaut.2021.102662_bib74","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.1148\/radiol.2020203557","article-title":"Pulmonary embolism and deep vein thrombosis in COVID-19: a systematic review and meta-analysis","volume":"298","author":"Suh","year":"2021","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.jaut.2021.102662_bib75","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat. Rev. Immunol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121000706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121000706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:28:46Z","timestamp":1760257726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841121000706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":75,"alternative-id":["S0896841121000706"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102662","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102662"}}